fda tirzepatide update today approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly fda update on tirzepatide Important

Were excited to introduce a new compounded GLP-1 option , specifically formulated with Vitamin B12 to support energy, metabolism, and tolerability

These include: weight gain digestive system side effects, such as: diarrhea constipation flatulence (gas) indigestion nausea and vomiting dizziness drowsiness headache nervousness tremor mild low blood sugar level In most cases, these side effects should be temporary

Both Hims and Eden offer access to GLP-1 injections and personalized oral weight loss medications

Benefic microbes

Levothyroxine should typically be taken on an empty stomach , at least 30 minutes before breakfast, with a full glass of water

Healthcare providers should educate patients on visual inspection techniques during initial training on injection administration